Promethera Biosciences Presents Updated Phase 2a Results for World’s First Stem Cell Clinical Trial in ACLF at The International Liver Congress™/ EASL 2019

Promethera Biosciences’ Interim safety results and early efficacy signals with HepaStem bodewell for subsequent confirmatory trials in ACLF and provide valuableinsights for imminent start of clinical evaluation in NASH

Read more